Abstract
Background
Epidemiological studies demonstrate a prevalence of Adamantiades-Behçet’s disease (ABD) in the range of 0.12–420 per 100,000 inhabitants, with the highest rates in Istanbul, Turkey, and the lowest rates in the USA. Ophthalmological data on the prevalence of ocular involvement are limited for ABD in Germany, because most epidemiological studies are based on rheumatological or dermatological data. Berlin is the city with the highest number of non-native German inhabitants, and its multi-ethnic character renders it uniquely appropriate for epidemiological studies on ABD.
Methods
We retrospectively analyzed all ABD patients seen in our department since 1982. All patients fulfilled the criteria of the International Study Group for Behçet’s Disease. We found 140 patients (63 female, 77 male), with a mean follow-up of 6.4 years (0.5–22 years).
Results
The mean age was 23 at the first manifestation and 32 when the full-blown disease was noted. The mean age at onset of ocular involvement was 30. Most of the patients were of Turkish (n = 73) or German (n = 34) origin. Fifty-six percent developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3% of cases.
Conclusions
More than half the patients developed ocular involvement. The calculated prevalence of ocular involvement in ABD is 1.77/100,000 inhabitants for the municipality of Berlin.


Similar content being viewed by others
References
Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol 192:149–155 doi:10.1007/s00430-002-0167-5
Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133–139
Krause L (2005) Adamantiades-Behcet’s disease. Ophthalmologe 102:329–334 doi:10.1007/s00347-004-1166-2
Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne (Paris) 150:488–498
Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24(suppl 42):S125, Erratum in Clin Exp Rheumatol (2007) 25:507–508
Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64, quiz 65–66 doi:10.1111/j.1610-0387.2006.05841.x
International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
Azizlerli G, Kose AA, Sarica R et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42:803–806 doi:10.1046/j.1365-4362.2003.01893.x
Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279
Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K (1999) Epidemiological features and visual prognosis of Behcet’s disease. Jpn J Ophthalmol 43:312–317 doi:10.1016/S0021-5155(99)00029-5
Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T (2006) Behcet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 25:364–367 doi:10.1007/s10067-005-0058-4
Shahram F, Davatchi F, Nadji A et al (2003) Recent epidemiological data on Behcet’s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31–36 doi:10.1007/0-306-48382-3_5
Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behcet’s disease in the 1980s and 1990s. Ophthalmology 111:810–815 doi:10.1016/j.ophtha.2003.07.018
Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G (1995) Behcet’s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246–251
Elgin U, Berker N, Batman A (2004) Incidence of secondary glaucoma in behcet disease. J Glaucoma 13:441–444 doi:10.1097/00061198-200412000-00002
Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380 doi:10.1016/j.ajo.2004.03.022
Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431
Krist D, Schönherr U, Wenkel H (2000) Adamantiadis-Behcet syndrome: fluorescein angiography and choroid ischemia. Klin Monatsbl Augenheilkd 216:45–50 doi:10.1055/s-2000-10515
Benezra D, Cohen E (1986) Treatment and visual prognosis in Behcet’s disease. Br J Ophthalmol 70:589–592 doi:10.1136/bjo.70.8.589
Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427
Ambresin A, Tran T, Spertini F, Herbort C (2002) Behcet’s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53–63 doi:10.1076/ocii.10.1.53.10326
Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599–603
Chung YM, Yeh TS, Sheu MM et al (1990) Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417
Muhaya M, Lightman S, Ikeda E et al (2000) Behcet’s disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148 doi:10.1076/0927-3948(200009)8:3;1-K;FT141
Escudier M, Bagan J, Scully C (2006) Number VII Behcet’s disease (Adamantiades syndrome). Oral Dis 12:78–84 doi:10.1111/j.1601-0825.2005.01144.x
Tanaka C, Matsuda T, Hayashi E, Imamura Y, Ozaki S (2003) Clinical manifestations and course of 200 Japanese patients with Behcet’s disease. Adv Exp Med Biol 528:77–79 doi:10.1007/0-306-48382-3_14
Saylan T, Ozarmagan G, Azizlerli G, Ovul C, Oke N (1986) Behcet disease in Turkey. Z Hautkr 61:1120–1122
Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s Disease. In: Zouboulis CC (ed) Adamantiades-Behçet’s Disease. Kluwer/Plenum, London Amsterdam, pp 123–126
Krause L, Köhler AK, Altenburg A et al (2008) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Jun):13. Epub ahead of print
Acknowledgement
The authors would like to thank Dr. Joanne Weirowski for her editorial contribution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krause, L., Köhler, AK., Altenburg, A. et al. Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 247, 661–666 (2009). https://doi.org/10.1007/s00417-008-0983-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0983-4